111 (NASDAQ:YI) Director Jian David Sun Sells 58,800 Shares

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 58,800 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $0.23, for a total transaction of $13,524.00. Following the sale, the director directly owned 413,211 shares of the company’s stock, valued at approximately $95,038.53. This represents a 12.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Thursday, June 11th, Jian David Sun sold 111,100 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $25,553.00.
• On Wednesday, June 10th, Jian David Sun sold 115,440 shares of 111 stock. The shares were sold at an average price of $0.22, for a total transaction of $25,396.80.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Price Performance

YI stock opened at $4.57 on Tuesday. 111, Inc. Sponsored ADR has a 52-week low of $2.48 and a 52-week high of $11.17. The company’s 50 day simple moving average is $5.88 and its 200-day simple moving average is $5.66. The firm has a market capitalization of $40.17 million, a P/E ratio of -3.26 and a beta of 0.60.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, 111 presently has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.